Pulmozyme Ampuls Recalled Because of Defect
Genentech Inc. is recalling Pulmozyme oral inhalation solution lot N9700A because some of the ampules have a tiny puncture and could leak.
The company said the ampules were damaged during manufacture. A similar problem occurred 13 months ago.
Pulmozyme, or dornase alfa, is used in the treatment of cystic fibrosis. The drug solution does not contain a preservative.